Truven Launches MarketScan Partner Ecosystem to Expand Real-World Evidence Options

First Horizon Bank Expands Financial Literacy Impact Through Its 2026 Teach Children to Save Program

Bald Eagle Stamps Take Flight

MemorialCare appoints Gary Purushotham CEO, names Sapna Mehta, D.O., chief medical officer at Long Beach Medical Center

Organic Yogurt Market to Reach USD 22.30 Billion by 2033 as Demand for Cleaner-Label Dairy and Plant-Based Alternatives Accelerates...

PINS INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Pinterest (PINS) Investors of Securities Class Action Deadline on May 29, 2026

Julius Tennon to serve as UTulsa's 2026 commencement speaker

All American Jerr-Dan Wreckers and Carriers Announces Expanded Availability of Towing and Recovery Equipment Across Additional New Jersey...

DELTEC HOMES UNVEILS NEW 360° SIGNATURE OPTIONS, GIVING HOMEOWNERS EVEN MORE WAYS TO PERSONALIZE ITS ICONIC ROUND HOMES

UHG INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds United Homes Group (UHG) Investors of Securities Class Action Deadline on June 9, 2026

TestMu AI Introduces Test.md, an Agent-Native Test Framework for Kane CLI

The CHOOCH Foundation Partners with IBEW Local 58 to Host "A Mind in Motion: Mental Health Maintenance Fair"

Crosslist Unveils Report on the Growing Importance of Multi-Platform Selling in Ecommerce

GLOB INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Globant S.A. (GLOB) Investors of Securities Class Action Deadline on June 23, 2026

Hamilton AI Launches Three New Products in Record Time

Exponent Raises $40M to Build the Financial Operating System for America's Franchise Operators

FSK SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds FS KKR Capital (FSK) Investors of Securities Class Action Deadline on July 3,...

National Advertising Division Finds Certain TerpLoc® Cannabis Packaging Claims Supported; Recommended Grove Bags Modify or Discontinue...

An InventHelp 123Invent Client Develops a Baseball and Softball Training Aid (LOS-276)

Imviva Biotech Presents Data Demonstrating Durable Clinical Responses from Ongoing Phase 1/2 Study of CTA313 in Systemic Lupus Erythematosus...